Literature DB >> 33942103

Youth Along the T2D Risk Continuum Remain Concerningly Refractory to Therapeutic Interventions.

Peter M Wolfgram1, Susanne M Cabrera2,1.   

Abstract

Entities:  

Keywords:  beta-cell function; insulin sensitivity; metformin; obesity; puberty

Mesh：

Year:  2021        PMID： 33942103      PMCID： PMC8208664          DOI： 10.1210/clinem/dgab292

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

1.  Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2019-06-09       Impact factor: 19.112

2.  Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

Authors:  Abbas E Kitabchi; Marinella Temprosa; William C Knowler; Steven E Kahn; Sarah E Fowler; Steven M Haffner; Reuben Andres; Christopher Saudek; Sharon L Edelstein; Richard Arakaki; Mary Beth Murphy; Harry Shamoon
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

3.  Liraglutide in Children and Adolescents with Type 2 Diabetes.

Authors:  William V Tamborlane; Margarita Barrientos-Pérez; Udi Fainberg; Helle Frimer-Larsen; Mona Hafez; Paula M Hale; Muhammad Y Jalaludin; Margarita Kovarenko; Ingrid Libman; Jane L Lynch; Paturi Rao; Naim Shehadeh; Serap Turan; Daniel Weghuber; Timothy Barrett
Journal:  N Engl J Med       Date:  2019-04-28       Impact factor: 91.245

4.  A clinical trial to maintain glycemic control in youth with type 2 diabetes.

Authors:  Phil Zeitler; Kathryn Hirst; Laura Pyle; Barbara Linder; Kenneth Copeland; Silva Arslanian; Leona Cuttler; David M Nathan; Sherida Tollefsen; Denise Wilfley; Francine Kaufman
Journal:  N Engl J Med       Date:  2012-04-29       Impact factor: 91.245

5.  Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp.

Authors: 
Journal:  Diabetes Care       Date:  2018-06-25       Impact factor: 19.112

6.  A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.

Authors:  Aaron S Kelly; Pernille Auerbach; Margarita Barrientos-Perez; Inge Gies; Paula M Hale; Claude Marcus; Lucy D Mastrandrea; Nandana Prabhu; Silva Arslanian
Journal:  N Engl J Med       Date:  2020-03-31       Impact factor: 91.245

7.  Two-Year Treatment With Metformin During Puberty Does Not Preserve β-Cell Function in Youth With Obesity.

Authors:  Megan M Kelsey; Allison Hilkin; Laura Pyle; Cameron Severn; Kristina Utzschneider; Rachael E Van Pelt; Philip S Zeitler; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

8.  Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.

Authors:  Michael Nauck; Anders Frid; Kjeld Hermansen; Nalini S Shah; Tsvetalina Tankova; Ismail H Mitha; Milan Zdravkovic; Maria Düring; David R Matthews
Journal:  Diabetes Care       Date:  2008-10-17       Impact factor: 17.152
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.